Black Rock Inc. Cogent Biosciences, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 6,689,618 shares of COGT stock, worth $56.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,689,618

Previous 6,755,584 0.98%

Holding current value

$56.4 Million

Previous $39.7 Million 13.17%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$4.38 - $9.02 $288,931 - $595,013	-65,966 Reduced 0.98%	6,689,618 $45 Million
Q4 2023 Feb 13, 2024	BUY	$4.06 - $10.08 $2.47 Million - $6.13 Million	608,506 Added 9.9%	6,755,584 $39.7 Million
Q3 2023 Nov 13, 2023	BUY	$9.69 - $13.34 $6.49 Million - $8.93 Million	669,416 Added 12.22%	6,147,078 $59.9 Million
Q2 2023 Aug 11, 2023	BUY	$9.85 - $13.24 $4.29 Million - $5.77 Million	435,592 Added 8.64%	5,477,662 $64.9 Million
Q1 2023 May 12, 2023	BUY	$10.04 - $15.5 $960,095 - $1.48 Million	95,627 Added 1.93%	5,042,070 $54.4 Million

Q4 2022 Feb 13, 2023	BUY	$10.65 - $14.84 $3.73 Million - $5.2 Million	350,140 Added 7.62%	4,946,443 $57.2 Million
Q3 2022 Nov 14, 2022	BUY	$9.39 - $16.99 $12.2 Million - $22.1 Million	1,299,523 Added 39.42%	4,596,303 $68.6 Million
Q2 2022 Aug 12, 2022	BUY	$3.92 - $9.73 $2.58 Million - $6.4 Million	657,409 Added 24.91%	3,296,780 $29.7 Million
Q1 2022 May 12, 2022	SELL	$5.31 - $8.7 $314,792 - $515,762	-59,283 Reduced 2.2%	2,639,371 $19.8 Million
Q4 2021 Feb 10, 2022	SELL	$7.51 - $10.81 $252,193 - $363,010	-33,581 Reduced 1.23%	2,698,654 $23.2 Million
Q3 2021 Nov 09, 2021	BUY	$5.99 - $9.14 $328,533 - $501,301	54,847 Added 2.05%	2,732,235 $23 Million
Q2 2021 Aug 11, 2021	BUY	$7.82 - $9.3 $20.9 Million - $24.9 Million	2,677,388 New	2,677,388 $21.7 Million

Others Institutions Holding COGT

# of Institutions

159

Shares Held

102M

Call Options Held

197K

Put Options Held

102K

View Full List

About Cogent Biosciences, Inc.

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $554M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

More about COGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account